HGH-191aa refers to recombinant human growth hormone — a synthetic version of the naturally occurring 191 amino acid growth hormone protein. It is identical in structure to pituitary-derived human growth hormone. It is FDA-approved for specific medical conditions and is one of the most well-studied protein hormones in clinical medicine, though its off-label use for performance and anti-aging purposes lacks strong evidence.
Growth Hormone Deficiency
Recombinant HGH is FDA-approved for growth hormone deficiency in children and adults. Large controlled trials demonstrate that it restores normal growth in GH-deficient children and improves body composition, bone density, and quality of life in GH-deficient adults.
Body Composition Research
In GH-deficient adults, HGH treatment produces significant increases in lean mass and reductions in fat mass. In adults without GH deficiency, the effects are smaller and the benefit-to-risk profile is less favorable. Research in normal older adults shows modest body composition changes but increased side effects.
Aging and Longevity Research
GH levels naturally decline with age. Research has examined whether HGH supplementation in older adults can reverse aspects of age-related physical decline. The NEJM Rudman study (1990) created popular interest, but subsequent research has not shown the hoped-for longevity or health benefits in people without GH deficiency.
Pediatric Applications
Beyond GH deficiency, HGH is approved for several specific pediatric conditions including Turner syndrome, Prader-Willi syndrome, and children born small for gestational age. These approvals are based on controlled trial evidence.
Highly effective for FDA-approved indications — GH deficiency in children and adults.
Significant body composition improvements in truly GH-deficient patients.
Modest and variable effects in people without GH deficiency, with increased side effect rates.
Anti-aging effects in healthy older adults are not well-established despite popular belief.
Long-term safety concerns include potential effects on cancer risk and metabolic parameters.
The research strongly supports HGH use in GH deficiency but does not strongly support it as an anti-aging or performance compound in people with normal GH levels. Side effects — including fluid retention, joint pain, carpal tunnel syndrome, glucose intolerance, and potential cancer risk — are meaningful, particularly at higher doses used outside of medical supervision. It is a prescription-only medication.
Your pituitary gland produces growth hormone in pulses, primarily during sleep and exercise. GH drives growth in children and continues to regulate body composition, bone density, and metabolism throughout life. It works by stimulating the liver and other tissues to produce IGF-1, which then acts on muscle, fat, and bone cells directly. As you age, GH production gradually declines. Recombinant HGH is a laboratory-produced version identical to what your pituitary makes. Injecting it directly replaces the signal, driving IGF-1 production and the downstream metabolic effects. In GH-deficient people, this restores a missing signal. In people who already produce normal GH, adding more does not necessarily produce proportional benefits and increases the risk of side effects.
FDA-approved with a well-established safety profile for approved medical uses. Side effects at therapeutic doses include fluid retention, joint and muscle pain, and potential worsening of insulin resistance. Long-term use at higher doses is associated with acromegaly-like effects, increased cardiovascular risk, and concerns about cancer promotion given IGF-1's role in cell growth signaling. Requires prescription and medical supervision.
High Evidence
This compound has been studied in multiple large randomized controlled trials with human subjects. The evidence base is strong and consistent across independent research groups.
Published Research Ranges
0.01–0.04mg/kg/day studied; varies significantly by indication in trials
Research Context Only: These are ranges reported in published scientific studies for educational reference. They are not dosing recommendations. This is not medical advice. Always consult a qualified healthcare professional.
Sources listed here are from the platform research library. All links open the original publication. No citations are generated by AI.
Recombinant Human Growth Hormone in Growth Hormone Deficiency: A Meta-Analysis
Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years
Effect of low-normal and high-normal IGF-1 levels on memory and wellbeing during growth hormone replacement therapy: a randomized clinical trial in adult growth hormone deficiency
Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement
Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study
Research Education Only: This profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions.
We use cookies to enhance your research experience and analyze platform usage. By continuing, you agree to our Cookie Policy.